MMS Banned in Germany
Dear friends: Victory in Germany!! MMS is prohibited. Yesterday there was a press release from a Federal authority that I've translated for you here. Now the air for Humble & Co. becomes thin in Germany.
"The Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM; Federal Institute for Drugs and Medical Products) classifies two "Miracle Mineral Supplement" products as subject to authorization and as questionable."
Press release 3/15
The BfArM has classified the "Miracle Mineral Supplement" products MMS and MMS2 of the company Luxury Line Ltd. as medicines requiring authorization. In addition, the BfArM sees these products as questionable, because there is reasonable suspicion that when used properly they have harmful effects that go beyond an acceptable level. Regulated drugs may be marketed only if efficacy, safety and quality have been proven in a regulatory approval process. The BfArM had already warned in May 2014 against sodium products that are usually advertised via the Internet as the "Miracle Mineral Supplement" to cure cancer, malaria, chronic infections and other serious diseases. With the current classification, against which the manufacturer may object within a month, the BfArM confirmed its critical attitude to the distribution and use of these products.
The BfArM has classed the two products MMS and MMS2 as so-called presentation drugs, because the manufacturer makes clear promises of cure and refers to medicinal purposes. On his website, www.mineral-mms.de, he gives exact dosing information and points to the possibility of serious side effects such as diarrhea and nausea. He also points out there to the book "Breakthrough" by Jim Humble, where he described the application and effectiveness of MMS in cases of malaria and cancer.
According to the German Drug Act, products are classified as presentation medicines that are intended to cure, mitigate or prevent diseases. Unlike with functional drugs, there is not decisive the pharmacological reaction of a substance, but the question of how a product is offered and how it is then understood by consumers. With this division the legislator wants to achieve that on the one hand products that are advertised with a healing testimony, and on the other hand, products with pharmacological qualities, even without proper designation, are controlled in terms of preventive patient protection and may not be placed on the market without official authorization.
In addition, the BfArM has classified both products as questionable drugs according to § 5 Drug Act, because taking them is associated with adverse effects beyond an acceptable level. MMS contains sodium chlorite solution 28%, MMS2 contains calcium hypochlorite 70% in capsules. Both products are brought on the market together with an "activator" -citric acid solution 10% for drinking water treatment. Through the reaction of MMS with the so-called activator, ie sodium chlorite and citric acid, chlorine dioxide is produced, a toxic gas with a pungent, chlorine-like odor. Chlorine dioxide is used as a bleach for paper and to disinfect drinking water and causes severe skin burns and eye damages. The poison emergency centers know of cases of vomiting, breathing problems and skin burns when taking MMS. In the United Kingdom, Canada, France, Switzerland and the United States, after taking MMS, undesirable effects such as nausea, vomiting, or diarrhea, kidney failure, burns of the esophagus and respiratory disorders were observed by damages to red blood cells.
The BfArM can classify a concrete product as a medicine if a state authority requested BfArM, pursuant to § 21 paragraph 4 Drug Law, to decide on the obligation to register as a drug. Such a request was made after the BfArM‘s warning in 2014. The decision of the BfArM sets the states (Laender) responsible for monitoring medicinal products in a position to initiate administrative police measures for the protection of patients, for example, to prohibit the importation or distribution of these products.